Causes Or Cures

Send us a textIn this episode, Dr. Eeks talks with Joel Stanley, entrepreneur and biotech founder, about the long and often misunderstood road from plant based therapies to FDA approved medicines.Joel shares the personal story behind building Charlotte’s Web, the company named after a young girl whose experience with severe epilepsy helped spark a global conversation about medical cannabis. He reflects on what it was like to grow a family run operation into a major force that reshaped public perception, while navigating science, regulation, and skepticism.The conversation then turns to Joel’s current work at Ajna BioSciences, where he is pursuing FDA approval for botanical drugs, including a botanical-based drug being studied for autism, with trials to be conducted in 2 countries. Joel explains where this research currently sits in the regulatory process and why he has chosen the traditional drug approval route rather than supplements or wellness markets.We also dig into the key differences between botanical